Overview of Dr. Schneider
Dr. Julie Schneider is a neurologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Loyola University Medical Center. She received her medical degree from University of Illinois College of Medicine at Chicago and has been in practice 30 years. She is one of 222 doctors at Rush University Medical Center and one of 313 doctors at Loyola University Medical Center who specialize in Neurology. She has more than 100 publications and over 500 citings.
Office
1750 W. Harrison St
Suite 1000
Chicago, IL 60612
Education & Training
- Emory University School of MedicineFellowship, Neuropathology, 1993 - 1994
- University of ChicagoResidency, Neurology, 1988 - 1993
- Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1987 - 1988
- University of Illinois College of MedicineClass of 1987
Certifications & Licensure
- IL State Medical License 1988 - 2026
- GA State Medical License 1993 - 1997
- American Board of Pathology Neuropathology
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Elevated neuroinflammation, autoimmunity, and altered IgG glycosylation profile in the cerebral spinal fluid of severe COVID-19 patients.Tanner Shull, Pavan Bhimalli, Samantha Welninski, Byoung-Kyu Cho, Basil Mattamana
Brain, Behavior, and Immunity. 2025-03-27 - Brain 5-hydroxymethylcytosine alterations are associated with Alzheimer's disease neuropathology.Jinying Zhao, Tongjun Gu, Cheng Gao, Guanhong Miao, Helena Palma-Gudiel
Nature Communications. 2025-03-22 - Novel modelling approaches to elucidate the genetic architecture of resilience to Alzheimer's disease.Jared M Phillips, Logan C Dumitrescu, Derek B Archer, Alexandra N Regelson, Shubhabrata Mukherjee
Brain. 2025-03-20
Journal Articles
- Sex Differences in Alzheimer’s Disease and Common Neuropathologies of AgingZoe Arvanitakis, Julie A Schneider, Lei Yu, David A Bennett, Acta Neuropathologica
- The Human Brainome: Network Analysis Identifies HSPA2 as a Novel Alzheimer’s Disease TargetChristine M Hulette, David A Bennett, Roger L Albin, Thomas G Beach, Randall L Woltjer, Andrew P Lieberman, John F Ervin, Anzhelika Engel, Julie A Schneider, Rui Chang, Brain
Press Mentions
- Strawberries May Help Fend off Alzheimer'sJuly 20th, 2022
- Newly Recognized Dementia Called LATE May Hit 40 Percent of Older PeopleJuly 13th, 2022
- Newly Recognized Dementia Called Late May Affects 40 Percent of Older PeopleJuly 13th, 2022
- Join now to see all
Grant Support
- Core--NeuropathologyNational Institute On Aging2006–2010
- Epidemiology, Pathology, And Parkinsonism In AgingNational Institute On Aging2000–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: